However, there is a lack of relevant research investigating how celastrol regulates the expression of HIF-1α and the PI3K/AKT/mTOR signaling pathway to treat B16-F10 melanoma cells, and the precise mechanism involved remains unclear. This evidence concerns the gene HIF1A and melanoma.